Similarly, while Egfr homodimers may not play a tumor maintenance role in previously untreated alveolar rhabdomyosarcoma, the possibility remains that refractory (chemotherapy or kinase inhibitor resistant) tumors may still in fact be driven by Egfr tyrosine kinase receptor signaling. Here, NTRK1 is linked to neoplasm.